These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 26726953

  • 1. Inhibition of Octreotide Acylation Inside PLGA Microspheres by Derivatization of the Amines of the Peptide with a Self-Immolative Protecting Group.
    Shirangi M, Najafi M, Rijkers DT, Kok RJ, Hennink WE, van Nostrum CF.
    Bioconjug Chem; 2016 Mar 16; 27(3):576-85. PubMed ID: 26726953
    [Abstract] [Full Text] [Related]

  • 2. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB, Goodman J, Thanoo BC, DeLuca PP.
    AAPS PharmSciTech; 2003 Oct 13; 4(4):E50. PubMed ID: 15198545
    [Abstract] [Full Text] [Related]

  • 3. Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC-MS/MS.
    Shirangi M, Hennink WE, Somsen GW, van Nostrum CF.
    Pharm Res; 2015 Sep 13; 32(9):3044-54. PubMed ID: 25832500
    [Abstract] [Full Text] [Related]

  • 4. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH, DeLuca PP.
    Pharm Res; 2005 May 13; 22(5):736-42. PubMed ID: 15906168
    [Abstract] [Full Text] [Related]

  • 5. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH, van Steenbergen MJ, Barendregt A, Talsma H, Kok RJ, van Nostrum CF, Crommelin DJ, Hennink WE.
    Pharm Res; 2012 Jan 13; 29(1):110-20. PubMed ID: 21744173
    [Abstract] [Full Text] [Related]

  • 6. Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.
    Vaishya RD, Mandal A, Gokulgandhi M, Patel S, Mitra AK.
    Int J Pharm; 2015 Jul 15; 489(1-2):237-45. PubMed ID: 25940041
    [Abstract] [Full Text] [Related]

  • 7. Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly(lactide-co-glycolide) delivery systems.
    Ahn JH, Park EJ, Lee HS, Lee KC, Na DH.
    AAPS PharmSciTech; 2011 Dec 15; 12(4):1220-6. PubMed ID: 21935743
    [Abstract] [Full Text] [Related]

  • 8. Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release.
    Vaishya RD, Mandal A, Patel S, Mitra AK.
    Int J Pharm; 2015 Dec 30; 496(2):676-88. PubMed ID: 26561725
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.
    Zhang Y, Sophocleous AM, Schwendeman SP.
    Pharm Res; 2009 Aug 30; 26(8):1986-94. PubMed ID: 19533307
    [Abstract] [Full Text] [Related]

  • 10. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.
    Liang D, Frank S, Schwendeman SP.
    Drug Deliv Transl Res; 2024 Mar 30; 14(3):696-704. PubMed ID: 38038895
    [Abstract] [Full Text] [Related]

  • 11. Acylation of arginine in goserelin-loaded PLGA microspheres.
    Shirangi M, Hennink WE, Somsen GW, van Nostrum CF.
    Eur J Pharm Biopharm; 2016 Feb 30; 99():18-23. PubMed ID: 26607434
    [Abstract] [Full Text] [Related]

  • 12. Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation.
    Murty SB, Na DH, Thanoo BC, DeLuca PP.
    Int J Pharm; 2005 Jun 13; 297(1-2):62-72. PubMed ID: 15885939
    [Abstract] [Full Text] [Related]

  • 13. Minimizing acylation of peptides in PLGA microspheres.
    Zhang Y, Schwendeman SP.
    J Control Release; 2012 Aug 20; 162(1):119-26. PubMed ID: 22546683
    [Abstract] [Full Text] [Related]

  • 14. Peptide acylation by poly(alpha-hydroxy esters).
    Lucke A, Kiermaier J, Göpferich A.
    Pharm Res; 2002 Feb 20; 19(2):175-81. PubMed ID: 11883645
    [Abstract] [Full Text] [Related]

  • 15. A new class of inhibitors of peptide sorption and acylation in PLGA.
    Sophocleous AM, Zhang Y, Schwendeman SP.
    J Control Release; 2009 Aug 04; 137(3):179-84. PubMed ID: 19318114
    [Abstract] [Full Text] [Related]

  • 16. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method.
    Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Schwendeman SP.
    Drug Deliv Transl Res; 2022 Mar 04; 12(3):695-707. PubMed ID: 34215997
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM, Eom HN, Jiang HH, Sohn M, Lee KC.
    J Pharm Sci; 2015 Jan 04; 104(1):72-80. PubMed ID: 25407390
    [Abstract] [Full Text] [Related]

  • 18. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method.
    Beig A, Ackermann R, Wang Y, Schutzman R, Schwendeman SP.
    Int J Pharm; 2022 Aug 25; 624():121842. PubMed ID: 35609832
    [Abstract] [Full Text] [Related]

  • 19. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J, Wang BM, Schwendeman SP.
    Biomaterials; 2004 May 25; 25(10):1919-27. PubMed ID: 14738856
    [Abstract] [Full Text] [Related]

  • 20. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
    Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Qin B, Schwendeman SP.
    Mol Pharm; 2020 Nov 02; 17(11):4141-4151. PubMed ID: 32876463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.